Skip to content

Clinical trials

Completed Carcinoma, Renal Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Completed Country / region: Canada Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20021
20034
20046
20053
20065
20075
20087
20093
20105
20116
20126
20131
20144
20151
20168
20176
20183
20195
20207
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed95

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
Pfizer8
Bristol-Myers Squibb7
Novartis Pharmaceuticals7
University Health Network, Toronto6
Merck Sharp & Dohme LLC5
AVEO Pharmaceuticals, Inc.3
Alliance for Clinical Trials in Oncology3
Argos Therapeutics3
Bayer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell95
Kidney Neoplasms24
Carcinoma, Non-Small-Cell Lung11
Melanoma10
Neoplasm Metastasis9
Neoplasms7
Squamous Cell Carcinoma of Head and Neck5
Breast Neoplasms4
Carcinoma, Transitional Cell4
Triple Negative Breast Neoplasms4

Trials

Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.